Skip to main content
Home
About Us
Our Mission
Management
Board of Directors
Science Advisors
Science & Pipeline
Overview
Neuroplasticity
DMX-1001
Alcohol use disorder
Publications
Investors & Media
Media releases
News beats
For Investors
Media contact
Contact DemeRx
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Appnet
Press Release
20 Jul at 2:17 pm
Read Article
Next Post
DemeRx Strengthens Leadership Team With Appointment of Biopharmaceutical Executive Michael Snitkovsky as Chief Operations Officer
Previous Post
DemeRx Adds Ibogaine Researcher Juan Sanchez-Ramos to Scientific Advisory Board
Menu
